查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2017714

宠物药品市场规模、份额和趋势分析报告：按产品类型、宠物类型、给药途径、药物类型、分销管道、地区和细分市场划分 - 预测，2026-2033 年

Pet Medicine Market Size, Share & Trends Analysis Report By Product, By Pet, By Route of Administration, By Drug Type, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

宠物药品市场概述

全球宠物药品市场预计到 2025 年将达到 145 亿美元，预计到 2033 年将达到 328 亿美元，2026 年至 2033 年的复合年增长率为 10.9%。

该行业的成长受到以下因素的推动：犬猫慢性疾病的日益普遍、疫苗接种和预防保健计划的扩展、兽医治疗和生物製药的创新，以及对伴侣动物研究的资金增加。

推动市场发展的主要因素是兽药和生技药品的快速创新，这为伴侣动物的慢性复杂疾病提供了更多治疗选择。製药公司和兽医研究机构正在推出借鉴人类医学创新成果的先进治疗方法，从而促进临床应用，并改善宠物的治疗效果。例如，美国食品药物管理局 (FDA) 于 2026 年 2 月核准了默克公司的 NUMELVI（阿替比替尼片）。本产品用于治疗方法犬过敏性皮肤炎。这是一种第二代Janus激酶 (JAK) 抑制剂，旨在抑制犬过敏性皮肤病引起的搔痒。在获得 FDA核准后，该产品成为同类产品中首个每日一次给药、直接靶向引起瘙痒和皮肤炎症的炎症细胞激素通路的兽药疗法。

生物製药在宠物医学领域也日益受到重视。像硕腾（Zoetis）这样的公司正在投资动物单株抗体的研究。这些治疗方法旨在高精度地靶向特定的疾病通路，目前已用于治疗伴侣动物的慢性疼痛和发炎性疾病。它们的作用机制与广泛用于人类医学的生物製药相似，凸显了人类医学和兽医学在药物创新方面的融合。另一个快速发展的领域是再生医学。兽医研究人员正越来越多地研究用于治疗宠物退化性疾病（例如骨关节炎和整形外科损伤）的干细胞疗法。这些治疗方法包括从动物体内收集和处理干细胞，然后将其重新註射到受损组织中，以促进癒合和组织再生。兽医医院正在犬猫身上测试这些治疗方法，以期取代侵入性手术和长期用药。

此外，精准医疗和免疫疗法正迅速发展成为新兴领域。研究计画正在探索标靶免疫疗法和基因组学方法，用于治疗伴侣动物的癌症等疾病。这些计画旨在根据基因或分子层面的疾病特征制定个人化治疗策略，从而提高治疗成功率并减少副作用。总之，生技药品、再生医学和标靶药物的进步正在改变宠物医药产业的格局。这些创新正在拓展治疗选择，并推动对先进兽医护理日益增长的需求。

目录

第一章：调查方法和范围

第二章执行摘要

第三章 市场：变数、趋势与范围

  • 市场谱系展望
  • 市场动态
  • 市场分析工具
  • 2025年各物种及主要国家宠物数量估计
  • 价格分析
  • 以使用者观点的分析
  • 关税影响分析
  • 宠物製药业的策略机会与风险

第四章：宠物药品市场：依宠物类型分類的估算与趋势分析

  • 宠物药品市场：按宠物类型分類的波动分析
  • 宠物药品市场：按动物种类分類的估算与预测，2021-2033年
  • 狗
  • 猫

第五章：宠物药品市场：基于产品的估算与趋势分析

  • 宠物药品市场：基于产品的波动分析
  • 宠物药品市场：依产品分類的估算与预测，2021-2033年
  • 生物製药
    • 疫苗
    • 其他生物製药
  • 製药
    • 寄生虫控制药物
    • 抗感染药物
    • 抗发炎药
    • 止痛药
    • 其他的
  • 药用饲料添加剂

第六章：宠物药品市场：依给药途径分類的估算与趋势分析

  • 宠物药品市场：按给药途径分類的波动分析
  • 宠物药品市场：按给药途径分類的估算与预测，2021-2033年
  • 口服
  • 注射药物
  • 外用
  • 其他给药途径

第七章：宠物药品市场：依药物类型分類的估算与趋势分析

  • 宠物药品市场：按药物类型分類的波动分析
  • 宠物药品市场：按药品类型分類的估算与预测，2021-2033年
  • 品牌商品
  • 学名药

第八章：宠物药品市场：按分销管道分類的估算和趋势分析

  • 宠物药品市场：按分销管道分類的波动分析
  • 宠物药品市场：按分销管道分類的估算与预测，2021-2033年
  • 兽医医院和诊所
  • 电子商务
  • 实体店面
  • 其他的

第九章：宠物药品市场：区域估算与趋势分析

  • 区域市场概览
  • 区域市场占有率分析（2025 年和 2033 年）
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
    • 荷兰
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • UAE
    • 沙乌地阿拉伯
    • 科威特
    • 卡达
    • 阿曼

第十章 竞争格局

  • 参与企业的分类
    • 市场领导
    • 新兴企业
  • 2025年市占率及估值分析（热图分析）
  • 公司简介
    • Zoetis Inc.
    • Boehringer Ingelheim International Gmbh
    • Merck & Co., Inc.
    • Elanco
    • Dechra Pharmaceuticals PLC
    • Ceva Sante Animale
    • Phibro Animal Health Corporation
    • Virbac
    • Bimeda Corporate
    • Biogenesis Bago
Product Code: GVR-4-68040-874-6

Pet Medicine Market Summary

The global pet medicine market size was estimated at USD 14.5 billion in 2025 and is projected to reach USD 32.8 billion by 2033, growing at a CAGR of 10.9% from 2026 to 2033. The industry is growing due to rising chronic diseases in dogs and cats, expansion of vaccination and preventive care programs, innovation in veterinary therapeutics and biologics, and increasing funding for companion animal research.

A key driver for the market is rapid innovation in veterinary therapeutics and biologics that is expanding treatment options for chronic and complex diseases in companion animals. Pharmaceutical companies and veterinary research groups are introducing advanced therapies that mirror innovations seen in human medicine, which is increasing clinical adoption and improving treatment outcomes for pets. One such instance is the February 2026 approval of Merck & Co.'s NUMELVI (atinvicitinib tablets) by the FDA; this product is used for dogs suffering from allergic dermatitis. The therapy is a second-generation Janus kinase (JAK) inhibitor designed to control pruritus associated with allergic skin diseases in dogs. The product received approval from the FDA and is the first veterinary therapy in its class, providing once-daily treatment that directly targets inflammatory cytokine pathways responsible for itching and skin inflammation.

Biologic therapies are also gaining traction in pet medicine. Companies such as Zoetis are investing in monoclonal antibody research for animals. These therapies are designed to target specific disease pathways with high precision and have already been used to manage conditions such as chronic pain and inflammatory disorders in companion animals. Their mechanism of action resembles biologic treatments widely used in human medicine, which highlights the convergence of human and veterinary drug innovation. Another area of rapid advancement is regenerative medicine. Veterinary researchers are increasingly exploring stem cell therapy for pets to treat degenerative conditions such as osteoarthritis and orthopedic injuries. These therapies involve collecting and processing stem cells from the animal and reintroducing them into damaged tissues to promote healing and tissue regeneration. Veterinary clinics are testing these treatments as alternatives to invasive surgery or long-term medication in dogs and cats.

Precision medicine and immunotherapy are also emerging as high-growth areas. Research initiatives are studying targeted immune therapies and genomic approaches to treat diseases such as cancer in companion animals. These programs aim to personalize treatment strategies based on genetic or molecular disease profiles, which can improve treatment success rates and reduce adverse effects. To conclude, advances in biologics, regenerative medicine, and targeted pharmaceuticals are reshaping the pet medicine sector. These innovations are expanding the therapeutic pipeline and driving higher demand for advanced veterinary treatments.

Global Pet Medicine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pet medicine market report based on product, pet, route of administration, distribution channel, drug type, and region.

  • Pet Outlook (Revenue, USD Million, 2021 - 2033)
  • Dogs
  • Cats
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Biologics
    • Vaccines
    • Modified/ Attenuated Live
    • Inactivated (Killed)
    • Other Vaccines
    • Other Biologics
  • Pharmaceuticals
    • Parasiticides
    • Anti-infectives
    • Anti-inflammatory
    • Analgesics
    • Others
  • Medicated Feed Additives
  • Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
  • Oral
  • Injectable
  • Topical
  • Other Routes
  • Drug Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Branded
  • Generics
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Veterinary Hospitals & Clinics
  • E-commerce
  • Offline Retail Stores
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
    • Netherlands
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Animal
    • 1.2.3. Route of Administration
    • 1.2.4. Drug Type
    • 1.2.5. Distribution Channel
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information/Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Model 1: Commodity Flow Analysis
    • 1.7.2. Model 2: Bottom-Up Analysis
    • 1.7.3. Model 3 Volume-Pricing Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary/Related Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Chronic Diseases In Dogs And Cats
      • 3.2.1.2. Expansion Of Vaccination And Preventive Care Programs
      • 3.2.1.3. Innovation In Veterinary Therapeutics And Biologics
      • 3.2.1.4. Increasing Funding For Companion Animal Research
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Drug Bans And Regulatory Restrictions
      • 3.2.2.2. Tariffs Increasing Veterinary Medicine Costs
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL by SWOT Analysis
  • 3.4. Estimated Pet Population By Species & Key Countries, 2025
  • 3.5. Pricing Analysis
  • 3.6. User Perspective Analysis
  • 3.7. Tariff Impact Analysis
    • 3.7.1. Sector Impact Analysis
    • 3.7.2. Geographical Impact Analysis
  • 3.8. Strategic Opportunities & Risk for the Pet Medicine Sector

Chapter 4. Pet Medicine Market: By Pet Estimates & Trend Analysis

  • 4.1. Pet Medicine Market, By Pet: Segment Dashboard
  • 4.2. Pet Medicine Market, By Pet Movement Analysis
  • 4.3. Pet Medicine Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
  • 4.4. Dogs
    • 4.4.1. Dogs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Cats
    • 4.5.1. Cats Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Pet Medicine Market: By Product Estimates & Trend Analysis

  • 5.1. Pet Medicine Market, By Product: Segment Dashboard
  • 5.2. Pet Medicine Market, By Product Movement Analysis
  • 5.3. Pet Medicine Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
  • 5.4. Biologics
    • 5.4.1. Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.2. Vaccines
      • 5.4.2.1. Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.4.2.1.1. Modified/ Attenuated Live
          • 5.4.2.1.1.1. Modified/ Attenuated Live Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.4.2.1.2. Inactivated (Killed)
          • 5.4.2.1.2.1. Inactivated (Killed) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.4.2.1.3. Other Vaccines
          • 5.4.2.1.3.1. Other Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.3. Other Biologics
      • 5.4.3.1. Other Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Pharmaceuticals
    • 5.5.1. Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. Parasiticides
      • 5.5.2.1. Parasiticides Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3. Anti-infectives
      • 5.5.3.1. Anti-infectives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.4. Anti-inflammatory
      • 5.5.4.1. Anti-inflammatory Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.5. Analgesics
      • 5.5.5.1. Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.6. Others
      • 5.5.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Medicated Feed Additives
    • 5.6.1. Medicated Feed Additives Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Pet Medicine Market: By Route of Administration Estimates & Trend Analysis

  • 6.1. Pet Medicine Market, By Route of Administration: Segment Dashboard
  • 6.2. Pet Medicine Market, By Route of Administration Movement Analysis
  • 6.3. Pet Medicine Market Estimates & Forecasts, by Route of Administration, 2021 to 2033 (USD Million)
  • 6.4. Oral
    • 6.4.1. Oral Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Injectable
    • 6.5.1. Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Topical
    • 6.6.1. Topical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Other Routes
    • 6.7.1. Other Routes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Pet Medicine Market: By Drug Type Estimates & Trend Analysis

  • 7.1. Pet Medicine Market, By Drug Type: Segment Dashboard
  • 7.2. Pet Medicine Market, By Drug Type Movement Analysis
  • 7.3. Pet Medicine Market Estimates & Forecasts, by Drug Type, 2021 to 2033 (USD Million)
  • 7.4. Branded
    • 7.4.1. Branded Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Generics
    • 7.5.1. Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Pet Medicine Market: By Distribution Channel Estimates & Trend Analysis

  • 8.1. Pet Medicine Market, By Distribution Channel: Segment Dashboard
  • 8.2. Pet Medicine Market, By Distribution Channel Movement Analysis
  • 8.3. Pet Medicine Market Estimates & Forecasts, by Distribution Channel, 2021 to 2033 (USD Million)
  • 8.4. Veterinary Hospitals & Clinics
    • 8.4.1. Veterinary Hospitals & Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. E-commerce
    • 8.5.1. E-commerce Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Offline Retail Stores
    • 8.6.1. Offline Retail Stores Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Others
    • 8.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Pet Medicine Market: By Regional Estimates & Trend Analysis

  • 9.1. Region Market Dashboard
  • 9.2. Region Market Share Analysis, 2025 & 2033
  • 9.3. North America
    • 9.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.2. U.S
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.2. UK
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Competitive Scenario
      • 9.4.8.3. Regulatory Framework
      • 9.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Competitive Scenario
      • 9.4.9.3. Regulatory Framework
      • 9.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.10. Netherlands
      • 9.4.10.1. Key Country Dynamics
      • 9.4.10.2. Competitive Scenario
      • 9.4.10.3. Regulatory Framework
      • 9.4.10.4. Netherlands Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competitive Scenario
      • 9.5.4.3. Regulatory Framework
      • 9.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.5. Australia
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Competitive Scenario
      • 9.5.5.3. Regulatory Framework
      • 9.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competitive Scenario
      • 9.5.6.3. Regulatory Framework
      • 9.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.7. South Korea
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competitive Scenario
      • 9.5.7.3. Regulatory Framework
      • 9.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Regulatory Framework
      • 9.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.3. UAE
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Regulatory Framework
      • 9.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.4. Saudi Arabia
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Competitive Scenario
      • 9.7.4.3. Regulatory Framework
      • 9.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Competitive Scenario
      • 9.7.5.3. Regulatory Framework
      • 9.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.6. Qatar
      • 9.7.6.1. Key Country Dynamics
      • 9.7.6.2. Competitive Scenario
      • 9.7.6.3. Regulatory Framework
      • 9.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.7. Oman
      • 9.7.7.1. Key Country Dynamics
      • 9.7.7.2. Competitive Scenario
      • 9.7.7.3. Regulatory Framework
      • 9.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
    • 10.1.1. Market Leaders
    • 10.1.2. Emerging Players
  • 10.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
  • 10.3. Company Profiles
    • 10.3.1. Zoetis Inc.
      • 10.3.1.1. Participant's Overview
      • 10.3.1.2. Financial Performance
      • 10.3.1.3. Product/Service Benchmarking
      • 10.3.1.4. Strategic Initiatives
    • 10.3.2. Boehringer Ingelheim International Gmbh
      • 10.3.2.1. Participant's Overview
      • 10.3.2.2. Financial Performance
      • 10.3.2.3. Product/Service Benchmarking
      • 10.3.2.4. Strategic Initiatives
    • 10.3.3. Merck & Co., Inc.
      • 10.3.3.1. Participant's Overview
      • 10.3.3.2. Financial Performance
      • 10.3.3.3. Product/Service Benchmarking
      • 10.3.3.4. Strategic Initiatives
    • 10.3.4. Elanco
      • 10.3.4.1. Participant's Overview
      • 10.3.4.2. Financial Performance
      • 10.3.4.3. Product/Service Benchmarking
      • 10.3.4.4. Strategic Initiatives
    • 10.3.5. Dechra Pharmaceuticals PLC
      • 10.3.5.1. Participant's Overview
      • 10.3.5.2. Financial Performance
      • 10.3.5.3. Product/Service Benchmarking
      • 10.3.5.4. Strategic Initiatives
    • 10.3.6. Ceva Sante Animale
      • 10.3.6.1. Participant's Overview
      • 10.3.6.2. Financial Performance
      • 10.3.6.3. Product/Service Benchmarking
      • 10.3.6.4. Strategic Initiatives
    • 10.3.7. Phibro Animal Health Corporation
      • 10.3.7.1. Participant's Overview
      • 10.3.7.2. Financial Performance
      • 10.3.7.3. Product/Service Benchmarking
      • 10.3.7.4. Strategic Initiatives
    • 10.3.8. Virbac
      • 10.3.8.1. Participant's Overview
      • 10.3.8.2. Financial Performance
      • 10.3.8.3. Product/Service Benchmarking
      • 10.3.8.4. Strategic Initiatives
    • 10.3.9. Bimeda Corporate
      • 10.3.9.1. Participant's Overview
      • 10.3.9.2. Financial Performance
      • 10.3.9.3. Product/Service Benchmarking
      • 10.3.9.4. Strategic Initiatives
    • 10.3.10. Biogenesis Bago
      • 10.3.10.1. Participant's Overview
      • 10.3.10.2. Financial Performance
      • 10.3.10.3. Product/Service Benchmarking
      • 10.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 Global Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 4 Global Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 5 Global Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 6 Global Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 7 Global Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 8 North America Pet Medicine Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 9 North America Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 10 North America Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 11 North America Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 12 North America Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 13 North America Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 14 U.S. Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 15 U.S. Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 16 U.S. Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 17 U.S. Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 18 U.S. Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 19 Canada Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 20 Canada Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 21 Canada Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 22 Canada Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 23 Canada Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 24 Mexico Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 25 Mexico Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 26 Mexico Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 27 Mexico Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 28 Mexico Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 29 Europe Pet Medicine Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 30 Europe Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 31 Europe Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 32 Europe Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 33 Europe Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 34 Europe Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 35 UK Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 36 UK Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 37 UK Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 38 UK Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 39 UK Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 40 Germany Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 41 Germany Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 42 Germany Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 43 Germany Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 44 Germany Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 45 France Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 46 France Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 47 France Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 48 France Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 49 France Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 50 Italy Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 51 Italy Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 52 Italy Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 53 Italy Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 54 Italy Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 55 Spain Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 56 Spain Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 57 Spain Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 58 Spain Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 59 Spain Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 60 Denmark Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 61 Denmark Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 62 Denmark Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 63 Denmark Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 64 Denmark Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 65 Sweden Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 66 Sweden Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 67 Sweden Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 68 Sweden Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 69 Sweden Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 70 Norway Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 71 Norway Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 72 Norway Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 73 Norway Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 74 Norway Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 75 Netherlands Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 76 Netherlands Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 77 Netherlands Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 78 Netherlands Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 79 Netherlands Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 80 Asia Pacific Pet Medicine Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 81 Asia Pacific Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 82 Asia Pacific Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 83 Asia Pacific Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 84 Asia Pacific Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 85 Asia Pacific Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 86 Japan Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 87 Japan Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 88 Japan Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 89 Japan Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 90 Japan Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 91 China Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 92 China Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 93 China Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 94 China Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 95 China Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 96 India Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 97 India Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 98 India Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 99 India Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 100 India Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 101 Australia Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 102 Australia Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 103 Australia Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 104 Australia Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 105 Australia Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 106 Thailand Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 107 Thailand Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 108 Thailand Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 109 Thailand Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 110 Thailand Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 111 South Korea Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 112 South Korea Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 113 South Korea Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 114 South Korea Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 115 South Korea Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 116 Latin America Pet Medicine Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 117 Latin America Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 118 Latin America Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 119 Latin America Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 120 Latin America Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 121 Latin America Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 122 Brazil Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 123 Brazil Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 124 Brazil Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 125 Brazil Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 126 Brazil Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 127 Argentina Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 128 Argentina Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 129 Argentina Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 130 Argentina Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 131 Argentina Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 132 Middle East & Africa Pet Medicine Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 133 Middle East & Africa Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 134 Middle East & Africa Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 135 Middle East & Africa Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 136 Middle East & Africa Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 137 Middle East & Africa Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 138 South Africa Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 139 South Africa Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 140 South Africa Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 141 South Africa Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 142 South Africa Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 143 UAE Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 144 UAE Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 145 UAE Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 146 UAE Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 147 UAE Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 148 Saudi Arabia Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 149 Saudi Arabia Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 150 Saudi Arabia Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 151 Saudi Arabia Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 152 Saudi Arabia Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 153 Kuwait Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 154 Kuwait Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 155 Kuwait Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 156 Kuwait Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 157 Kuwait Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 158 Qatar Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 159 Qatar Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 160 Qatar Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 161 Qatar Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 162 Qatar Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 163 Oman Pet Medicine Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 164 Oman Pet Medicine Market Estimates and Forecasts, by Pet, 2021 - 2033 (USD Million)
  • Table 165 Oman Pet Medicine Market Estimates and Forecasts, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 166 Oman Pet Medicine Market Estimates and Forecasts, by Drug Type, 2021 - 2033 (USD Million)
  • Table 167 Oman Pet Medicine Market Estimates and Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Commodity Flow Analysis
  • Fig. 7 Value Chain-Based Sizing & Forecasting
  • Fig. 8 QFD Model Sizing & Forecasting
  • Fig. 9 Bottom-Up Approach
  • Fig. 10 Market Snapshot
  • Fig. 11 Segment Snapshot 1
  • Fig. 12 Segment Snapshot 2
  • Fig. 13 Competitive Landscape Snapshot
  • Fig. 14 Parent Market Outlook, 2025 (USD Billion)
  • Fig. 15 Ancillary Market Outlook, 2025 (USD Billion)
  • Fig. 16 Pet Medicine Market Dynamics
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 PESTEL Analysis
  • Fig. 19 Pet Medicine Market: Product Outlook and Key Takeaways
  • Fig. 20 Pet Medicine Market: Product Movement Analysis
  • Fig. 21 Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Modified/attenuated live Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Inactivated (killed) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Other vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Other Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Parasiticides Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Anti-infectives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Anti-inflammatory Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Medicated feed additives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Pet Medicine Market: Pet Outlook and Key Takeaways
  • Fig. 35 Pet Medicine Market: Pet Movement Analysis
  • Fig. 36 Dogs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Cats Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Pet Medicine Market: Route of Administration Outlook and Key Takeaways
  • Fig. 39 Pet Medicine Market: Route of Administration Movement Analysis
  • Fig. 40 Oral Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Topical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Other Routes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Pet Medicine Market: Drug Type Outlook and Key Takeaways
  • Fig. 45 Pet Medicine Market: Drug Type Movement Analysis
  • Fig. 46 Branded Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Pet Medicine Market: Distribution Channel Outlook and Key Takeaways
  • Fig. 49 Pet Medicine Market: Distribution Channel Movement Analysis
  • Fig. 50 Veterinary Hospitals & Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 E-commerce Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Offline Retail Stores Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Regional Marketplace: Key Takeaways
  • Fig. 55 North America Pet Medicine Market Estimates and Forecasts, 2021-2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 U.S. Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Canada Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Mexico Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Europe Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 UK Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Germany Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 France Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Italy Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Spain Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Denmark Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Sweden Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Norway Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Netherlands Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Asia Pacific Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Japan Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 China Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 India Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Australia Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Thailand Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 South Korea Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 Latin America Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Brazil Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Argentina Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 100 MEA Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 South Africa Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 UAE Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 Saudi Arabia Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Kuwait Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 109 Key country dynamics
  • Fig. 110 Qatar Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 111 Key country dynamics
  • Fig. 112 Oman Pet Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)